RUMI, MARIAGRAZIA
RUMI, MARIAGRAZIA
Dipartimento di Scienze Cliniche e di Comunità
A 28-Year Study of the Course of Hepatitis Delta Infection : A Risk Factor for Cirrhosis and Hepatocellular Carcinoma
2009 R. Romeo, E. Del Ninno, M.G. Rumi, A. Russo, A. Sangiovanni, R. De Franchis, G. Ronchi, M. Colombo
A morphometric and immunohistochemical study to assess the benefit of an svr in hcv cirrhotic patients
2012 R. D'Ambrosio, A. Aghemo, M. Rumi, G. Ronchi, M.F. Donato, V. Paradis, M. Colombo, P. Bedossa
A multicenter controlled, randomized, open trial of interferon alpha2b treatment of anti-human immunodeficiency virus-negative hemophilic patients with chronic hepatitis C
1997 M.G. Rumi, E. Santagostino, M. Morfini, A. Gringeri, G. Tagariello, A. Chistolini, P. Pontisso, A. Tagger, M. Colombo, P.M. Mannucci, H. Study Group of the Association of Italian Hemophilia Centers
A sequential predictive algorithm combining APRI and transient elastography (TE) for diagnosing liver fibrosis in chronic hepatitis C
2009 M. Fraquelli, C. Rigamonti, A. Colli, D. Conte, S. Della Valle, S. Massironi, M. Rumi, M.F. Donato, G. Ronchi, M. Colombo
A sequential predictive algorithm combining APRI and transient elastography (TE) for diagnosing liver fibrosis in chronic hepatitis C
2008 M. Fraquelli, C. Rigamonti, G. Casazza, A. Colli, M.G. Rumi, D. Conte, M.F. Donato, G. Ronchi, M. Colombo
A sequential predictive algorithm combining APRI and transient elastography for diagnosing liver fibrosis in chronic hepatitis C
2008 M. Fraquelli, C. Rigamonti, G. Casazza, A. Colli, M.G. Rumi, D. Conte, F. Donato, G. Ronchi, M. Colombo
Accelerated schedule of hepatitis B vaccination in patients with hemophilia
1993 E. Santagostino, P. M. Mannucci, A. Gringeri, M. Rumi, D. Rafanelli, A. Rocino, M. Schiavoni, A. Chistolini, E. Di Bona, G. Muleo
Accuracy of FIB-4 to Detect Elevated Liver Stiffness Measurements in Patients with Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Referral Centers
2022 M. Viganò, N. Pugliese, F. Cerini, F. Turati, V. Cimino, S. Ridolfo, S. Rocchetto, F. Foglio, M. Terrin, C. La La Vecchia, M.G. Rumi, A. Aghemo
Anemia during peginterferon-ribavirin therapy results from both increased suppression of erythroid differentiation and haemolysis
2008 A. Aghemo, L. Ronzoni, M. Rumi, S. Monico, A. Colancecco, P. Grillo, M. Viganò, M.D. Cappellini, M. Colombo
Anemia during pegylated interferon-ribavirin therapy results from both increase suppression of erythroid differentiation and hemolysis
2009 L. Ronzoni, A. Aghemo, M. Rumi, A. Colancecco, S. Monico, P. Grillo, M. Colombo, M.D. Cappellini
Anti-LAV/HTLV-III antibodies in groups of individuals at high risk for infection in Italy
1985 A.R. Zanetti, P. Ferroni, M. Colombo, A. Cargnel, D. Mari, G. Zehender, M. Rumi, A. Gringeri, M. Ammassari, P.M. Mannucci
Anti-LAV/HTLV-III antibodies in high and low risk groups
1987 A.R. Zanetti, G. Zehender, E. Tanzi, M.G. Rumi, D. Mari, P. Ferroni
Antiviral Therapy for HCV-Associated Cryoglobulinemic Glomerulonephritis : Case Report and Review of the Literature
2013 F. Fabrizi, G. Fogazzi, D. Cresseri, P. Passerini, P. Martin, M. Donato, M. Rumi, P. Messa
Case Report: A Challenging Localization of a Pulmonary Ectopic ACTH-Secreting Tumor in a Patient With Severe Cushing’s Syndrome
2021 A.L. Serban, L. Rosso, P. Mendogni, A. Cremaschi, R. Indirli, B. Mantovani, M. Rumi, M. Castellani, A. Chiti, G.A. Croci, G. Mantovani, M. Nosotti, E. Ferrante, M. Arosio
Cirrhosis and rapid virological response to peginterferon plus ribavirin determine treatment outcome in HCV-1 IL28B rs12979860 CC patients
2013 A. Aghemo, E. Degasperi, M.G. Rumi, E. Galmozzi, L. Valenti, R. De Francesco, S. De Nicola, C. Cheroni, E. Grassi, M. Colombo
Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long-term analogue therapy for hepatitis B
2018 A. Loglio, M. Iavarone, G. Grossi, M. Viganò, M.G. Rumi, F. Facchetti, G. Lunghi, A. Sangiovanni, M. Colombo, P. Lampertico
Comparative trials of peginterferon α2a and peginterferon α2b for chronic hepatitis C
2012 M. Rumi, A.M. Aghemo, G.M. Prati
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort
2020 A. Soria, M. Fava, D.P. Bernasconi, G. Lapadula, E. Colella, M.G. Valsecchi, G.M. Migliorino, R. D'Ambrosio, S. Landonio, M. Schiavini, A. Spinetti, C. Carriero, E. Degasperi, G. Cologni, F. Gatti, P. Vigano, H. Hasson, C. Uberti-Foppa, L. Pasulo, C. Baiguera, R. Rossotti, M. Vinci, M. Puoti, A. Giorgini, B. Menzaghi, A. Lombardi, A. Pan, A. Aghemo, P.A. Grossi, R. Boldizzoni, S. Colombo, M. Vigano, M.G. Rumi, P. Del Poggio, L. Valenti, O. Giglio, A. De Bona, A. d'Arminio Monforte, A. Colombo, O. Spinelli, M.G. Pigozzi, C. Molteni, P. Bonfanti, N. Terreni, P. Perini, A. Capretti, D. Bella, C. Liani, S. Polo, G. Aimo, L. Pagnucco, S. Bhoori, R. Centenaro, M. Graffeo, A. Ciaccio, E. Dionigi, S. Lazzaroni, I. Carderi, M. Di Marco, G. Rizzardini, F. Noventa, P. Lampertico, S. Fagiuoli
Concomitant therapy with direct-acting antivirals and chemoimmunotherapy in HCV-associated diffuse large B-cell lymphoma
2018 V. Occhipinti, L. Farina, M. Viganò, M. Capecchi, S. Labanca, I. Fanetti, P. Corradini, M. Rumi
Contrast imaging techniques to diagnose hepatocellular carcinoma in cirrhotics outside regular surveillance
2019 M. Iavarone, M. Vigano, N. PIAZZA O SED, V. Occhipinti, A. Sangiovanni, M. Maggioni, G. D'Ambrosio, L.V. Forzenigo, F. Motta, P. Lampertico, M.-. Rumi, M. Colombo